Silent Eye Damage in Diabetic Kids

Doctor holding tablet about type 2 diabetes — Photo: one photo / Shutterstock

Doctors can now spot damage to a child’s eyes caused by diabetes years before any doctor could see it with a standard exam.

Quick Take

A study of 294 young people with type 1 diabetes found thinning in key retina layers even without visible diabetic eye disease.
Higher average blood sugar, measured by hemoglobin A1c, was linked to thinner layers in the retina’s nerve and outer regions.
The thinning showed up regardless of how long someone had diabetes, pointing to blood sugar control as the key factor.
Researchers call the retina changes a possible early warning sign, not yet a proven predictor of future vision problems.

What Researchers Found In Young Patients’ Eyes

Scientists used a scanning tool called optical coherence tomography, or OCT, to take detailed pictures of the retina in 294 kids and young adults, ages 9 to 21, who have type 1 diabetes. None of them had diabetic eye disease that a doctor could see during a regular exam. Yet the scans picked up something a regular exam could not: thinning in specific retina layers tied to higher blood sugar levels.

The retina has several layers, each doing a different job. Researchers focused on the ganglion cell and inner plexiform layers, which carry visual signals toward the brain, along with the outer retinal layers. Both areas showed measurable thinning as hemoglobin A1c numbers climbed. Hemoglobin A1c is a blood test that shows average blood sugar over about three months, making it a standard tool doctors use to judge diabetes control.

The Numbers Behind The Blood Sugar Link

The math tells a clear but modest story. For every unit increase in hemoglobin A1c, the ganglion cell and inner plexiform layers thinned by about 0.39 micrometers, a statistically meaningful but small change. The outer retinal layers thinned more, by about 0.81 micrometers per unit increase. Both results cleared the bar for statistical significance, meaning they likely were not due to chance.

What stood out just as much was what did not matter. The thinning was not tied to how long a child had lived with diabetes, and it was not clearly tied to whether they already had diagnosed diabetic eye disease. Blood sugar control, not diabetes duration, carried the stronger connection to retina changes in this study.

Why This Study Builds On Earlier Warning Signs

This research doesn’t stand alone. Earlier work on 73 children with type 1 diabetes also found thinner retina measurements tied to blood sugar levels, with the authors concluding that retina changes visible on OCT may show up before any blood vessel damage a doctor could otherwise detect. A broader review pooling multiple studies likewise found thinner neuroretinal layers in diabetic eyes without retinopathy compared to those without diabetes, reinforcing the pattern across different research teams.

Not every past study lines up perfectly. A 2018 study of children with type 1 diabetes found retina thinning too, but it did not find a link to hemoglobin A1c or how long someone had diabetes. Differences in which retina regions researchers measured, and how they defined those layers, likely explain some of the mismatch. Still, the overall direction across these studies points the same way: nerve damage in the eye can start quietly, long before it’s visible.

Where The Evidence Still Needs To Catch Up

The study’s authors were careful about one thing. This research shows a connection at a single point in time. It does not prove that high blood sugar caused the thinning, and it does not confirm that the thinning will turn into real vision loss or diabetic retinopathy later. The researchers are calling for longer studies that track the same kids over years to settle that question.

Europe flagged this 17 months earlier. EMA's safety committee (6 June 2025) listed NAION as a "very rare" semaglutide side effect: about 1 extra case per 10,000 person-years, from observational studies in type 2 diabetes. That review covered semaglutide only, not tirzepatide.

— Footnote (@onefootnote) November 10, 2026

There’s also a practical limit worth noting. Only 2 percent of the study group had moderate diabetic retinopathy, so the numbers connecting OCT thinning to that more advanced disease stage weren’t strong enough to draw firm conclusions. No doctor today has a confirmed threshold number that says “this much thinning means treatment is needed.” For now, the retina scan is a research tool flagging early risk, not a replacement for the standard screening and blood sugar management that type 1 diabetes care already demands. Parents managing a child’s diabetes should treat this as one more reason tight blood sugar control matters, not as a reason to panic over a new eye test.